ETHEROS PHARMACEUTICALS CORP.

Profile

Company Names

ETHEROS PHARMACEUTICALS CORP.

Addresses

111 10TH AVE S, STE 110, NASHVILLE, TN 37203

Phone Numbers

615-212-9695

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$1,675,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-01-31 
$600,000.00 
$600,000.00 
$0.00 
 
2
2023-11-06 
$300,000.00 
$300,000.00 
$0.00 
 
1
2023-02-20 
$775,000.00 
$775,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUBHASISH 
 
CHAKRABORTY 
EXECUTIVE OFFICER
ETHEROS PHARMACEUTICALS CORP.
LAURA 
 
DUGAN 
DIRECTOR
ETHEROS PHARMACEUTICALS CORP.
MARC 
 
FELDMANN 
DIRECTOR
180 LIFE SCIENCES CORP.   |  ETHEROS PHARMACEUTICALS CORP.
FRANCIS 
 
KNUETTEL 
DIRECTOR
SCWORX CORP.   |  180 LIFE SCIENCES CORP.   |  ETHEROS PHARMACEUTICALS CORP.   |  CHROMOCELL THERAPEUTICS CORP
FRANCIS 
 
KNUETTEL II 
DIRECTOR
IP COMMERCE INC   |  MARATHON PATENT GROUP, INC.   |  SPINDLE, INC.   |  MJAR HOLDINGS CORP.   |  TERRA TECH CORP.   |  UNRIVALED BRANDS, INC.   |  ETHEROS PHARMACEUTICALS CORP.   |  PELTHOS THERAPEUTICS INC.
JOHN 
WILLIAM 
SCANNELL 
EXECUTIVE OFFICER, DIRECTOR
ETHEROS PHARMACEUTICALS CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2025-01-31 
2023-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2023-02-20 
2023-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2023-11-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#